Thermo Fisher Scientific Inc. revenue by segment TMO

Annual Quarterly

Thermo Fisher Scientific Inc. splits its revenue 2 ways in its filings. By operating segments, the largest line in Q3 of fiscal 2026, the quarter ended Sep 26, 2026 was Laboratory Products And Biopharma Services at $6.8 billion, 56% of the total. By sales mix, the largest line in Q3 of fiscal 2026, the quarter ended Sep 26, 2026 was Services at $5.4 billion, 44% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Sep 26, 2026	Q3 FY2026 Sep 26, 2026	Q2 FY2026 Jun 27, 2026	Q1 FY2026 Mar 28, 2026	Q4 FY2025 Dec 31, 2025	Q3 FY2025 Sep 27, 2025	Q2 FY2025 Jun 28, 2025	Q1 FY2025 Mar 29, 2025	Q4 FY2024 Dec 31, 2024
Revenue	47,351	12,137	11,994	11,005	12,215	11,122	10,855	10,364	11,395
Operating segments
Laboratory Products And Biopharma Services	25,802 +10.4% share 54.5%	6,820 +15.1% share 56.2%	6,652 +11.7% share 55.5%	5,995 +7.0% share 54.5%	6,335 +7.4% share 51.9%	5,927 share 53.3%	5,953 share 54.8%	5,603 share 54.1%	5,896 share 51.7%
Life Sciences Solutions	9,371 +10.4% share 19.8%	2,279 +3.9% share 18.8%	2,355 +11.3% share 19.6%	2,219 +13.6% share 20.2%	2,518 +13.2% share 20.6%	2,194 share 19.7%	2,115 share 19.5%	1,954 share 18.9%	2,225 share 19.5%
Analytical Instruments	7,574 +3.4% share 16.0%	1,948 +5.5% share 16.1%	1,799 +7.8% share 15.0%	1,667 -0.6% share 15.1%	2,160 +1.2% share 17.7%	1,847 share 16.6%	1,669 share 15.4%	1,677 share 16.2%	2,135 share 18.7%
Specialty Diagnostics	4,604 +1.4% share 9.7%	1,090 -5.5% share 9.0%	1,188 +6.3% share 9.9%	1,124 -0.5% share 10.2%	1,202 +5.5% share 9.8%	1,154 share 10.4%	1,118 share 10.3%	1,130 share 10.9%	1,139 share 10.0%
Sales mix
Services	20,252 +11.0% share 42.8%	5,384 +16.2% share 44.4%	5,171 +12.3% share 43.1%	4,728 +7.8% share 43.0%	4,969 +7.4% share 40.7%	4,633 share 41.7%	4,605 share 42.4%	4,384 share 42.3%	4,627 share 40.6%
Product Consumables	19,691 +8.5% share 41.6%	4,870 +4.1% share 40.1%	5,073 +10.1% share 42.3%	4,722 +8.5% share 42.9%	5,026 +11.3% share 41.1%	4,679 share 42.1%	4,606 share 42.4%	4,354 share 42.0%	4,517 share 39.6%
Product Instruments	7,409 +1.1% share 15.6%	1,883 +4.0% share 15.5%	1,750 +6.4% share 14.6%	1,555 -4.4% share 14.1%	2,221 -1.3% share 18.2%	1,811 share 16.3%	1,644 share 15.1%	1,626 share 15.7%	2,250 share 19.7%

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Measuring & Controlling Devices, NEC (SIC 3829)
Listed as: TMO (NYSE)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Waltham, MA
SEC filer status: Large accelerated filer
SEC CIK: 97745
Former names: THERMO ELECTRON CORP (until Nov 3, 2006)

Other Measuring & Controlling Devices, NEC companies

All 11 Measuring & Controlling Devices, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.